The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.
Study Type
OBSERVATIONAL
Enrollment
67,028
Beijing An Zhen Hospital
Beijing, China
The overall composite of six performance measures for AF care
Performance measures for AF care including: 1. Proportion of patients received assessment of thromboembolic risk factors 2. Proportion of patients discharged on warfarin or other anticoagulant drug 3. Proportion of patients discharged on warfarin who have PT/INR follow-up planned prior to hospital discharge 4. Proportion of patients with left ventricular systolic dysfunction prescribed an ACEI or ARB at hospital discharge 5. Proportion of patients with left ventricular systolic dysfunction prescribed a beta blocker at hospital discharge 6. Proportion of patients with either coronary artery disease, cerebrovascular accident/transient ischemic attack, peripheral vascular disease or diabetes who were prescribed a statin at hospital discharge
Time frame: Duration of hospital stay, an expected average of 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.